• Mashup Score: 6

    Join us for this and future episodes to learn from experts as they discuss recent Neurology journal articles and hot topics in the field of neurology. Articles and discussants are selected by the editors of Neurology. Professor of Pediatrics, Director Pediatrics MS and Neuroinflammatory Disorders Program, Senior Scientist, University of Toronto The Hospital for Sick Children Research Daniela Castillo Villagr á n, MD Pediatric Neurologist, Clinical Fellow Pediatric MS & Neuroinflammatory Disorders

    Tweet Tweets with this article
    • Neurology Video Journal Club: Drs. Ann Yeh & Daniela Castillo Villagrán discuss an article about differentiating #MS from AQP4-NMOSD and #MOGAD with imaging. Watch now: https://t.co/3MUkCNCxk5 Read the related article: https://t.co/I96053rJBB @sickkids #NeuroTwitter https://t.co/b49lEmd9OS

  • Mashup Score: 4
    2023 RNDS - 8 month(s) ago

    The one-day regional in-person educational and advocacy conference for those affected by rare neuroimmune disorders.

    Tweet Tweets with this article
    • Registration is now open for the 2023 Regional Rare Neuroimmune Disorders Symposium in Dallas, TX on October 7. Hosted by @wearesrna and @utsw, this is a one-day regional educational and advocacy event. Learn more here: https://t.co/AUEGcRbpgl #StrongerTogether #NMOSD #MOGAD

  • Mashup Score: 0

    International criteria for the diagnosis of myelin oligodendrocyte glycoprotein–associated disease (MOGAD) were published in The Lancet Neurology ® on January 24, 2023.1 The criteria recommend that patients with a clinical event typically associated with MOG antibody (Ab) (optic neuritis, myelitis, acute disseminated encephalomyelitis, cerebral monofocal or polyfocal deficits, brainstem or…

    Tweet Tweets with this article
    • Navigating Through the Recent Diagnostic Criteria for MOGAD: Challenges and Practicalities https://t.co/9nlcKWaL7b #Neurology #NeuroTwitter #MOGAD

  • Mashup Score: 8

    Background and Objectives Studies on tumefactive brain lesions in myelin oligodendrocyte glycoprotein-immunoglobulin G (IgG)–associated disease (MOGAD) are lacking. We sought to characterize the frequency clinical, laboratory, and MRI features of these lesions in MOGAD and compare them with those in multiple sclerosis (MS) and aquaporin-4-IgG–positive neuromyelitis optica spectrum disorder…

    Tweet Tweets with this article
    • This study characterizes the frequency clinical, laboratory, and MRI features of tumefactive brain lesions in #MOGAD and compares them with those in multiple sclerosis (#MS) and aquaporin-4-IgG–positive neuromyelitis optica spectrum disorder (AQP4+NMOSD). https://t.co/b1VcqhqaaM https://t.co/Mv5ot7x2IF

  • Mashup Score: 5

    Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) is a recently described CNS inflammatory disorder that may manifest with optic neuritis, myelitis, seizures, and/or acute disseminated encephalomyelitis. While MOG-specific antibodies in patients with MOGAD are IgG1, a T-cell–dependent antibody isotype, immunologic mechanisms of this disease are not fully understood. Thymic…

    Tweet Tweets with this article
    • This report from the National Multiple Sclerosis Society Case Conference Proceedings describes a case of #MOGAD associated with thymic hyperplasia in a young adult. Read the open access article: https://t.co/tYVQmdsRbz https://t.co/kaiWIOuR1r